Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pagel

Showing results (91-100 of 245) with videos related to

Pageof 25
Sort By:
Nuclear Medicine Communications|July 31, 2014
90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistributionManuela Matesan, Joseph Rajendran, Oliver W Press, et al.
Haematologica|December 21, 2014
Correlation between peripheral blood and bone marrow regarding FLT3-ITD and NPM1 mutational status in patients with acute myeloid leukemiaWei-Gang Tong, Vicky K Sandhu, Brent L Wood, et al.
Haematologica|November 30, 2023
Pirtobrutinib <i>versus</i> venetoclax in covalent Bruton tyrosine kinase inhibitor-pretreated chronic lymphocytic leukemia: a matching-adjusted indirect comparisonOthman Al-Sawaf, Min-Hua Jen, Lisa M Hess, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2010
NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignanciesEdwin P Alyea, Daniel J DeAngelo, Jeffrey Moldrem, et al.
Blood|April 22, 2011
⁹⁰Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphomaAjay K Gopal, Katherine A Guthrie, Joseph Rajendran, et al.
Blood|November 26, 2002
Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomasJohn M Pagel, Nathan Hedin, Krishnan Subbiah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomasJohn M Pagel, Christian Laugen, Lynn Bonham, et al.
American Journal of Hematology|May 2, 2020
Management of CLL patients early in the COVID-19 pandemic: An international survey of CLL expertsBrian Koffman, Anthony Mato, John C Byrd, et al.
Cancer|July 16, 2008
High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experienceAjay K Gopal, Tracee L Metcalfe, Ted A Gooley, et al.
British Journal of Haematology|May 27, 2015
Comparative analysis of flow cytometry and morphology for the detection of acute myeloid leukaemia cells in cerebrospinal fluidKeith R Loeb, Sindhu Cherian, Pamela S Becker, et al.
Pageof 25

Showing results (91-100 of 245) with videos related to

Sort By:
Pageof 25
Nuclear Medicine Communications|July 31, 2014
90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistributionManuela Matesan, Joseph Rajendran, Oliver W Press, et al.
Haematologica|December 21, 2014
Correlation between peripheral blood and bone marrow regarding FLT3-ITD and NPM1 mutational status in patients with acute myeloid leukemiaWei-Gang Tong, Vicky K Sandhu, Brent L Wood, et al.
Haematologica|November 30, 2023
Pirtobrutinib <i>versus</i> venetoclax in covalent Bruton tyrosine kinase inhibitor-pretreated chronic lymphocytic leukemia: a matching-adjusted indirect comparisonOthman Al-Sawaf, Min-Hua Jen, Lisa M Hess, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2010
NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignanciesEdwin P Alyea, Daniel J DeAngelo, Jeffrey Moldrem, et al.
Blood|April 22, 2011
⁹⁰Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphomaAjay K Gopal, Katherine A Guthrie, Joseph Rajendran, et al.
Blood|November 26, 2002
Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomasJohn M Pagel, Nathan Hedin, Krishnan Subbiah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomasJohn M Pagel, Christian Laugen, Lynn Bonham, et al.
American Journal of Hematology|May 2, 2020
Management of CLL patients early in the COVID-19 pandemic: An international survey of CLL expertsBrian Koffman, Anthony Mato, John C Byrd, et al.
Cancer|July 16, 2008
High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experienceAjay K Gopal, Tracee L Metcalfe, Ted A Gooley, et al.
British Journal of Haematology|May 27, 2015
Comparative analysis of flow cytometry and morphology for the detection of acute myeloid leukaemia cells in cerebrospinal fluidKeith R Loeb, Sindhu Cherian, Pamela S Becker, et al.
Pageof 25